Grab your favorite coffee. This is where you’ll find all the substance you require, and more.
Cognivia Announces Collaboration to Advance Behavioral Intelligence Across Clinical Research and Clinical Care
The collaboration with Mayo Clinic will initially focus on non-adherence, missed medical appointments, and clinical trial retention behavioral factors that can influence outcomes, continuity, and trial execution….
Correcting For The Individual Patient Regression To The Mean Effect
Often, the primary endpoint of RCTs is defined as a change from baseline of a continuous outcome. In…
Interview on The Bio Report Podcast
Erica Smith, VP of Business Development, speaks with Daniel Levin of The Bio Report Podcast about the Placebell©™ method to reduce the impact of the placeb response in drug development”.
The Case Against Excluding High Placebo Responders from Clinical Trials
Drug developers have been struggling with the placebo response for decades, as a strong placebo effect diminishes the ability to distinguish pharmacologic treatment efficacy of an experimental…
Putting Patient Uniqueness at the heart of Innovation
Access to innovative therapies remains an issue. In certain diseases, the magnitude and variability of individuals’ placebo response…
Patient-Centric Approach To Characterizing Placebo response
Learn about how Tools4Patient considers the placebo response of each individual patient in clinical trials as a central part of the Placebell© methodology.
Video Interview at Biotech Showcase 2019
Erica Smith, VP of Business Development, discusses the benefits of the Placebell©™ approach in video interview at Biotech Showcase in San Francisco, CA. Date: January, 2019
Understand patient differences in your next clinical trial
Increase your trial’s success rates and bring new therapies to patients faster.
Tell us about your clinical trial below, and our team will be in touch.
"*" indicates required fields